Home Interviews BioStock Investor Meeting: Redwood Pharma presents

BioStock Investor Meeting: Redwood Pharma presents

RedwoodPharma_MartinVidaeus_BioStockInvestorMeeting

BioStock Investor Meeting: Redwood Pharma presents

21 September, 2022

When BioStock Investor Meeting took place in Stockholm, Redwood Pharma’s CEO Martin Vidaeus was there to present the company. In his presentation, Vidaeus highlighted the development of the company’s leading product RP501, for the treatment of dry eyes, and talked about Redwood Pharma’s strategic goals.

 See Redwood Pharma’s presentation below:

The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.

Prenumerera på BioStocks nyhetsbrev